Heck Capital Advisors’s Avanos Medical AVNS Stock Holding History

Heck Capital Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-12	Closed	-$191	–	285
2024 Q4	$191	Buy	+12	New	+$237	﹤0.01%	784

Other funds holding AVNS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Heck Capital Advisors's AVNS Position: Q1 2025 in Review

Heck Capital Advisors sold out of Avanos Medical (AVNS) in Q1 2025, closing a stake of 12 shares — an estimated $191 sold.

Heck Capital Advisors first reported a position in AVNS in Q4 2024 and held it in 1 quarter. The position peaked at $191 in Q4 2024. 277 funds tracked by Wall St. Rank hold AVNS as of Q1 2025.

Heck Capital Advisors reported no remaining Avanos Medical position as of Q1 2025 after selling out during the quarter.
Heck Capital Advisors sold 12 Avanos Medical shares in Q1 2025, an estimated $191.
Heck Capital Advisors first reported a position in Avanos Medical in Q4 2024 and held it in 1 quarter.
Heck Capital Advisors's Avanos Medical position peaked at $191 in Q4 2024.
277 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2025.

Based on Heck Capital Advisors's 13F filing for Q1 2025, filed 13 May 2025.